The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Nikitovic, Dragana ^a   Kouvidi, Katerina ^a   Karamanos, Nikos K ^b   Tzanakakis, George N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; HERMES ANTIGEN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BB; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONAN-MEDIATED MOTILITY RECEPTOR; SCLEROPROTEIN; PROTEIN BINDING;

CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CHILDHOOD CANCER; COMPLEX FORMATION; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; EXTRACELLULAR MATRIX; FIBROSARCOMA; FOCAL ADHESION; GENE OVEREXPRESSION; HUMAN; INTRACELLULAR SIGNALING; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT TRANSFORMATION; MITOSIS SPINDLE; PROTEIN INTERACTION; REVIEW; SKIN CARCINOGENESIS; SPINDLE CELL SARCOMA; STROMA CELL; TISSUE STRUCTURE; UPREGULATION; CARCINOGENESIS; DISEASE COURSE; METABOLISM; PATHOLOGY; PROTEIN BINDING;

ANTIGENS, CD44; CARCINOGENESIS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FIBROSARCOMA; HUMANS; HYALURONIC ACID; PROTEIN BINDING;

EID: 84884860382     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/929531     Document Type: Review

References (164)

1. Yokota J., Tumor progression and metastasis. Carcinogenesis 2000 21 3 497 503 2-s2.0-0034108271 (Pubitemid 30137935)
2. Tímár J., Lapis K., Dudás J., Sebestyén A., Kopper L., Kovalszky I., Proteoglycans and tumor progression: janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology 2002 12 3 173 186 2-s2.0-0035988837 10.1016/S1044-579X(02)00021-4 (Pubitemid 34833061)
3. Kransdorf M. J., Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. American Journal of Roentgenology 1995 164 1 129 134 2-s2.0-0028817551
4. Stiller C. A., Parkin D. M., International variations in the incidence of childhood soft-tissue sarcomas. Paediatric and Perinatal Epidemiology 1994 8 1 107 119 2-s2.0-0028084916 (Pubitemid 24034284)
5. Schmidt H., Taubert H., Würl P., Kappler M., Lange H., Bartel F., Bache M., Holzhausen H.-J., Hinze R., Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes and Cancer 2002 34 1 69 77 2-s2.0-0036209240 10.1002/gcc.10036 (Pubitemid 34260598)
6. Knezevich S. R., Garnett M. J., Pysher T. J., Beckwith J. B., Grundy P. E., Sorensen P. H. B., ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Research 1998 58 22 5046 5048 2-s2.0-0032533497 (Pubitemid 28521157)
7. Wingo P. A., Tong T., Bolden S., Cancer statistics. CA Cancer Journal for Clinicians 1995 45 1 8 30 2-s2.0-0028835677
8. Wibmer C., Leithner A., Zielonke N., Sperl M., Windhager R., Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Annals of Oncology 2009 21 5 1106 1111 2-s2.0-77953355156 10.1093/annonc/mdp415
9. Bahrami A., Folpe A. L., Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. American Journal of Surgical Pathology 2010 34 10 1504 1513 2-s2.0-77957933902 10.1097/PAS.0b013e3181ef70b6
10. Verweij J., Baker L. H., Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations. European Journal of Cancer 2010 46 5 863 868 2-s2.0-77349116791 10.1016/j.ejca.2010.01.016
11. Theocharis A. D., Skandalis S. S., Tzanakakis G. N., Karamanos N. K., Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS Journal 2010 277 19 3904 3923 2-s2.0-77956641177 10.1111/j.1742-4658.2010.07800.x
12. Schaefer L., Schaefer R. M., Proteoglycans: from structural compounds to signaling molecules. Cell and Tissue Research 2010 339 1 237 246 2-s2.0-72449147268 10.1007/s00441-009-0821-y
13. Järveläinen H., Sainio A., Koulu M., Wight T. N., Penttinen R., Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacological Reviews 2009 61 2 198 223 2-s2.0-67649446995 10.1124/pr.109.001289
14. Hynes R. O., Integrins: bidirectional, allosteric signaling machines. Cell 2002 110 6 673 687 2-s2.0-0037145037 10.1016/S0092-8674(02)00971-6 (Pubitemid 35283958)
15. Maxwell C. A., McCarthy J., Turley E., Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? Journal of Cell Science 2008 121 7 925 932 2-s2.0-43149106462 10.1242/jcs.022038 (Pubitemid 351639411)
16. Sanderson R. D., Yang Y., Suva L. J., Kelly T., Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biology 2004 23 6 341 352 2-s2.0-7944230119 10.1016/j.matbio.2004.08.004 (Pubitemid 39469549)
17. Xu R., Boudreau A., Bissell M. J., Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer and Metastasis Reviews 2009 28 1-2 167 176 2-s2.0-68549085276 10.1007/s10555-008- 9178-z
18. Wiseman B. S., Sternlicht M. D., Lund L. R., Alexander C. M., Mott J., Bissell M. J., Soloway P., Itohara S., Werb Z., Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. Journal of Cell Biology 2003 162 6 1123 1133 2-s2.0-0141768243 10.1083/jcb.200302090 (Pubitemid 37174194)
19. Stickens D., Behonick D. J., Ortega N., Heyer B., Hartenstein B., Yu Y., Fosang A. J., Schorpp-Kistner M., Angel P., Werb Z., Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004 131 23 5883 5895 2-s2.0-19944426775 10.1242/dev.01461 (Pubitemid 40123905)
20. Rebustini I. T., Myers C., Lassiter K. S., Surmak A., Szabova L., Holmbeck K., Pedchenko V., Hudson B. G., Hoffman M. P., MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Developmental Cell 2009 17 4 482 493 2-s2.0-70349988123 10.1016/j.devcel.2009.07.016
21. Lu P., Takai K., Weaver V. M., Werb Z., Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspectives in Biology 2011 3 12 10.1101/cshperspect.a005058.
22. Nikitovic D., Tzanakakis G., Extracellular Matrix 2011 Berlin, Germany Walter de Gruyter
23. Provenzano P. P., Eliceiri K. W., Campbell J. M., Inman D. R., White J. G., Keely P. J., Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Medicine 2006 4, article 38 2-s2.0-33846782878 10.1186/1741-7015-4-38 (Pubitemid 46210997)
24. Levental K. R., Yu H., Kass L., Lakins J. N., Egeblad M., Erler J. T., Fong S. F. T., Csiszar K., Giaccia A., Weninger W., Yamauchi M., Gasser D. L., Weaver V. M., Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009 139 5 891 906 2-s2.0-70450222098 10.1016/j.cell.2009.10. 027
25. Lu P., Weaver V. M., Werb Z., The extracellular matrix: a dynamic niche in cancer progression. Journal of Cell Biology 2012 196 4 395 406 2-s2.0-84859949610 10.1083/jcb.201102147
26. Nikitovic D., Chatzinikolaou G., Tsiaoussis J., Tsatsakis A., Karamanos N. K., Tzanakakis G. N., Insights into targeting colon cancer cell fate at the level of proteoglycans/glycosaminoglycans. Current Medicinal Chemistry 2012 19 4247 4258
27. Gialeli C., Theocharis A. D., Karamanos N. K., Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS Journal 2011 278 1 16 27 2-s2.0-78650424066 10.1111/j.1742-4658.2010.07919. x
28. Bhowmick N. A., Neilson E. G., Moses H. L., Stromal fibroblasts in cancer initiation and progression. Nature 2004 432 7015 332 337 2-s2.0-9244227134 10.1038/nature03096 (Pubitemid 39551661)
29. Cirri P., Chiarugi P., Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer and Metastasis Reviews 2012 31 195 208 2-s2.0-81555236371 10.1007/s10555-011-9340-x
30. Ilan N., Elkin M., Vlodavsky I., Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. International Journal of Biochemistry and Cell Biology 2006 38 12 2018 2039 2-s2.0-33748683743 10.1016/j.biocel.2006.06.004 (Pubitemid 44397619)
31. Kessenbrock K., Plaks V., Werb Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010 141 1 52 67 2-s2.0-77950931419 10.1016/j.cell.2010.03.015
32. Barkan D., Green J. E., Chambers A. F., Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. European Journal of Cancer 2010 46 7 1181 1188 2-s2.0-77950594400 10.1016/j.ejca.2010.02. 027
33. Skandalis S. S., Aletras A. J., Gialeli C., Targeting the tumor proteasome as a mechanism to control the synthesis and bioactivity of matrix macromolecules. Current Medicinal Chemistry 2012 12 8 1068 1082
34. Berdiaki A., Nikitovic D., Tsatsakis A., Katonis P., Karamanos N. K., Tzanakakis G. N., bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells. Biochimica et Biophysica Acta-General Subjects 2009 1790 10 1258 1265 2-s2.0-69949088085 10.1016/j.bbagen.2009.06.013
35. Piepkorn M., Hovingh P., Linker A., Evidence for independent metabolism and cell surface localization of cellular proteoglycans and glycosaminoglycan free chains. Journal of Cellular Physiology 1988 135 2 189 199 2-s2.0-0023933608
36. Berdiaki A., Zafiropoulos A., Fthenou E., Katonis P., Tsatsakis A., Karamanos N. K., Tzanakakis G. N., Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochimica et Biophysica Acta-General Subjects 2008 1780 2 194 202 2-s2.0-38549176061 10.1016/j.bbagen.2007.10.005 (Pubitemid 351162894)
37. Weigel P. H., Hascall V. C., Tammi M., Hyaluronan synthases. Journal of Biological Chemistry 1997 272 22 13997 14000 2-s2.0-0030956931 10.1074/jbc.272.22.13997 (Pubitemid 27232793)
38. Tammi R. H., Kultti A., Kosma V.-M., Pirinen R., Auvinen P., Tammi M. I., Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Seminars in Cancer Biology 2008 18 4 288 295 2-s2.0-44749083057 10.1016/j.semcancer.2008.03.005
39. Itano N., Kimata K., Mammalian hyaluronan synthases. IUBMB Life 2002 54 4 195 199 2-s2.0-0036819199 10.1080/15216540214929 (Pubitemid 36008328)
40. Csoka A. B., Frost G. I., Stern R., The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biology 2001 20 8 499 508 2-s2.0-0035202430 10.1016/S0945-053X(01)00172-X (Pubitemid 33109098)
41. Toole B. P., Hyaluronan in morphogenesis. Journal of Internal Medicine 1997 242 1 35 40 2-s2.0-0030766519 (Pubitemid 27323863)
42. Evanko S. P., Tammi M. I., Tammi R. H., Wight T. N., Hyaluronan-dependent pericellular matrix. Advanced Drug Delivery Reviews 2007 59 13 1351 1365 2-s2.0-36048930461 10.1016/j.addr.2007.08.008 (Pubitemid 350088257)
43. Balazs E. A., Denlinger J. L., Clinical uses of hyaluronan. Ciba Foundation Symposium 1989 143 265 275 2-s2.0-0024368010
44. McKee C. M., Penno M. B., Cowman M., Burdick M. D., Strieter R. M., Bao C., Noble P. W., Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. Journal of Clinical Investigation 1996 98 10 2403 2413 2-s2.0-0029808003 (Pubitemid 26394217)
45. Horton M. R., McKee C. M., Bao C., Liao F., Farber J. M., Hodge-DuFour J., Puré E., Oliver B. L., Wright T. M., Noble P. W., Hyaluronan fragments synergize with interferon- γ to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. Journal of Biological Chemistry 1998 273 52 35088 35094 2-s2.0-0032567492 10.1074/jbc.273.52.35088 (Pubitemid 29028210)
46. Teriete P., Banerji S., Noble M., Blundell C. D., Wright A. J., Pickford A. R., Lowe E., Mahoney D. J., Tammi M. I., Kahmann J. D., Campbell I. D., Day A. J., Jackson D. G., Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Molecular Cell 2004 13 4 483 496 2-s2.0-10744221425 10.1016/S1097-2765(04)00080-2 (Pubitemid 38299377)
47. Zoltan-Jones A., Huang L., Ghatak S., Toole B. P., Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. Journal of Biological Chemistry 2003 278 46 45801 45810 2-s2.0-0242412978 10.1074/jbc.M308168200 (Pubitemid 37432725)
48. Jameson J. M., Cauvi G., Sharp L. L., Witherden D. A., Havran W. L., γ δ T cell-induced hyaluronan production by epithelial cells regulates inflammation. Journal of Experimental Medicine 2005 201 8 1269 1279 2-s2.0-18244374740 10.1084/jem.20042057 (Pubitemid 40629070)
49. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G. D., Mascarenhas M. M., Garg H. G., Quinn D. A., Homer R. J., Goldstein D. R., Bucala R., Lee P. J., Medzhitov R., Noble P. W., Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Medicine 2005 11 11 1173 1179 2-s2.0-30744462300 10.1038/nm1315 (Pubitemid 43093664)
50. Itano N., Atsumi F., Sawai T., Yamada Y., Miyaishi O., Senga T., Hamaguchi M., Kimata K., Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proceedings of the National Academy of Sciences of the United States of America 2002 99 6 3609 3614 2-s2.0-0037133564 10.1073/pnas.052026799 (Pubitemid 34252154)
51. Pirinen R., Tammi R., Tammi M., Prognostic value of hyaluronan expression in non-small-cell lung cancer: increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. International Journal of Cancer 2001 95 1 12 7
52. Klagas I., Goulet S., Karakiulakis G., Zhong J., Baraket M., Black J. L., Papakonstantinou E., Roth M., Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. European Respiratory Journal 2009 34 3 616 628 2-s2.0-70349138334 10.1183/09031936.00070808
53. West D. C., Hampson I. N., Arnold F., Kumar S., Angiogenesis induced by degradation products of hyaluronic acid. Science 1985 228 4705 1324 1336 2-s2.0-0021834944 (Pubitemid 15000359)
54. McKee C. M., Lowenstein C. J., Horton M. R., Wu J., Bao C., Chin B. Y., Choi A. M. K., Noble P. W., Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor B-dependent mechanism. Journal of Biological Chemistry 1997 272 12 8013 8018 2-s2.0-0030944222 10.1074/jbc.272.12.8013 (Pubitemid 27137366)
55. Day A. J., Sheehan J. K., Hyaluronan: polysaccharide chaos to protein organisation. Current Opinion in Structural Biology 2001 11 5 617 622 (Pubitemid 32972026)
56. Day A. J., Prestwich G. D., Hyaluronan-binding proteins: tying up the giant. Journal of Biological Chemistry 2002 277 7 4585 4588 2-s2.0-0037085372 10.1074/jbc.R100036200 (Pubitemid 34968483)
57. Toole B. P., Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews Cancer 2004 4 7 528 539 2-s2.0-3042697038 (Pubitemid 38868622)
58. Turley E. A., Noble P. W., Bourguignon L. Y. W., Signaling properties of hyaluronan receptors. Journal of Biological Chemistry 2002 277 7 4589 4592 2-s2.0-0037085254 10.1074/jbc.R100038200 (Pubitemid 34968484)
59. Segura T., Anderson B. C., Chung P. H., Webber R. E., Shull K. R., Shea L. D., Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 2005 26 4 359 371 2-s2.0-3242658198 10.1016/j. biomaterials.2004.02.067 (Pubitemid 38951103)
60. Cai S., Xie Y., Bagby T. R., Cohen M. S., Forrest M. L., Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. Journal of Surgical Research 2008 147 2 247 252 2-s2.0-43549084331 10.1016/j.jss.2008.02.048
61. Underhill C., CD44: the hyaluronan receptor. Journal of Cell Science 1992 103 2 293 298 2-s2.0-0026446637
62. Toole B. P., Wight T. N., Tammi M. I., Hyaluronan-cell interactions in cancer and vascular disease. Journal of Biological Chemistry 2002 277 7 4593 4596 2-s2.0-0037085376 10.1074/jbc.R100039200 (Pubitemid 34968485)
63. Lokeshwar V. B., Rubinowicz D., Schroeder G. L., Forgacs E., Minna J. D., Block N. L., Nadji M., Lokeshwar B. L., Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. Journal of Biological Chemistry 2001 276 15 11922 11932 2-s2.0-0035853711 10.1074/jbc.M008432200
64. Knudson W., Toole B. P., Membrane association of the hyaluronate stimulatory factor from LX-1 human lung carcinoma cells. Journal of Cellular Biochemistry 1988 38 3 165 177 2-s2.0-0024208153 (Pubitemid 19017339)
65. Edward M., Gillan C., Micha D., Tammi R. H., Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion. Carcinogenesis 2005 26 7 1215 1223 2-s2.0-22844437793 10.1093/carcin/bgi064 (Pubitemid 41417898)
66. Calikoglu E., Augsburger E., Chavaz P., Saurat J.-H., Kaya G., CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Journal of Cutaneous Pathology 2003 30 3 185 189 2-s2.0-0037360718 10.1034/j.1600-0560.2003.300304.x (Pubitemid 36428427)
67. Pienimäki J.-P., Rilla K., Fülöp C., Sironen R. K., Karvinen S., Pasonen S., Lammi M. J., Tammi R., Hascall V. C., Tammi M. I., Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. Journal of Biological Chemistry 2001 276 23 20428 20435 2-s2.0-0242544016 10.1074/jbc.M007601200
68. Karvinen S., Pasonen-Seppänen S., Hyttinen J. M. T., Pienimäki J.-P., Törrönen K., Jokela T. A., Tammi M. I., Tammi R., Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. The Journal of Biological Chemistry 2003 278 49 49495 49504 2-s2.0-1542571994
69. Pasonen-Seppänen S., Karvinen S., Törrönen K., Hyttinen J. M. T., Jokela T., Lammi M. J., Tammi M. I., Tammi R., EGF upregulates, whereas TGF- β downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. Journal of Investigative Dermatology 2003 120 6 1038 1044 2-s2.0-0038129491 10.1046/j.1523-1747.2003.12249.x (Pubitemid 36702915)
70. Weigel P. H., DeAngelis P. L., Hyaluronan synthases: a decade-plus of novel glycosyltransferases. Journal of Biological Chemistry 2007 282 51 36777 36781 2-s2.0-37549017360 10.1074/jbc.R700036200
71. Nikitovic D., Zafiropoulos A., Katonis P., Tsatsakis A., Theocharis A. D., Karamanos N. K., Tzanakakis G. N., Transforming growth factor- β as a key molecule triggering the expression of versican isoforms V0 and V1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life 2006 58 1 47 53 2-s2.0-33645105798 10.1080/15216540500531713
72. Yabushita H., Noguchi M., Kishida T., Fusano K., Noguchi Y., Itano N., Kimata K., Noguchi M., Hyaluronan synthase expression in ovarian cancer. Oncology Reports 2004 12 4 739 743 2-s2.0-14044260232
73. Yamada Y., Itano N., Narimatsu H., Kudo T., Morozumi K., Hirohashi S., Ochiai A., Ueda M., Kimata K., Elevated transcript level of hyaluronan synthasel gene correlates with poor prognosis of human colon cancer. Clinical and Experimental Metastasis 2004 21 1 57 63 2-s2.0-1642285879 10.1023/B:CLIN. 0000017203.71293.e0 (Pubitemid 38365658)
74. Girish K. S., Kemparaju K., The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sciences 2007 80 21 1921 1943 2-s2.0-34247119777 10.1016/j.lfs.2007.02.037 (Pubitemid 46601516)
75. Stair-Nawy S., Csóka A. B., Stern R., Hyaluronidase expression in human skin fibroblasts. Biochemical and Biophysical Research Communications 1999 266 1 268 273 2-s2.0-0343048976 10.1006/bbrc.1999.1802 (Pubitemid 30028803)
76. Stern R., Hyaluronidases in cancer biology. Seminars in Cancer Biology 2008 18 275 280
77. Kosaki R., Watanabe K., Yamaguchi Y., Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Research 1999 59 5 1141 1145 2-s2.0-0033106004 (Pubitemid 29135978)
78. Chang N.-S., Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D. Cell Biochemistry and Biophysics 1996 27 2 109 132 2-s2.0-0001385243 (Pubitemid 126682721)
79. Menon P., Smith K. J., Crittenden J., Skelton H., Adjuvant therapy with hyaluronidase prior to excision of dermatofibrosarcoma protuberans. Dermatologic Surgery 1999 25 3 205 209 2-s2.0-0032974504 10.1046/j.1524-4725.1999.08148.x (Pubitemid 29146987)
80. Smith K., Menon P., Rolfe A., Welch M., Barrett T., Crittenden M. J., Skelton H., Pretreatment with intralesional hyaluronidase prior to excision of dermatofibrosarcoma protuberans. Cancer Letters 1998 131 1 117 126 2-s2.0-0032508524 10.1016/S0304-3835(98)00208-0 (Pubitemid 28467048)
81. Stern R., Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003 13 12 105R 115R 2-s2.0-0344668719 10.1093/glycob/cwg112 (Pubitemid 37508893)
82. Madan A. K., Yu K., Dhurandhar N., Cullinane C., Pang Y., Beech D. J., Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncology Reports 1999 6 3 607 609 2-s2.0-0033129693
83. Godin D. A., Fitzpatrick P. C., Scandurro A. B., Belafsky P. C., Woodworth B. A., Amedee R. G., Beech D. J., Beckman B. S., PH-20: a novel tumor marker for laryngeal cancer. Archives of Otolaryngology 2000 126 3 402 404 2-s2.0-0033621922 (Pubitemid 30140398)
84. Lokeshwar V. B., Lokeshwar B. L., Pham H. T., Block N. L., Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Research 1996 56 3 651 657 2-s2.0-0030059196 (Pubitemid 26043668)
85. Lokeshwar V. B., Cerwinka W. H., Lokeshwar B. L., HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Research 2005 65 6 2243 2250 2-s2.0-16844364920 10.1158/0008-5472.CAN-04-2805 (Pubitemid 40490133)
86. Jacobson A., Rahmanian M., Rubin K., Heldin P., Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. International Journal of Cancer 2002 102 3 212 219 2-s2.0-0037145745 10.1002/ijc.10683 (Pubitemid 35222286)
87. Agren U. M., Tammi R. H., Tammi M. I., Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radical Biology and Medicine 1997 23 7 996 1001 2-s2.0-0030832062 10.1016/S0891-5849(97) 00098-1 (Pubitemid 27451286)
88. Nikitovic D., Pratsinis H., Berdiaki A., Gialeli C., Kletsas D., Tzanakakis G.N., Extracellular Matrix 2011 Berlin, Germany Walter de Gruyter
89. Sironen R. K., Tammi M., Tammi R., Auvinen P. K., Anttila M., Kosma V.-M., Hyaluronan in human malignancies. Experimental Cell Research 2011 317 4 383 391 2-s2.0-78651466170 10.1016/j.yexcr.2010.11.017
90. Schoppmann S. F., Birner P., Stöckl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., Kerjaschki D., Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. American Journal of Pathology 2002 161 3 947 956 2-s2.0-0036733564 (Pubitemid 34988382)
91. Lin E. Y., Li J.-F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D. A., Qian H., Xue X.-N., Pollard J. W., Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Research 2006 66 23 11238 11246 2-s2.0-33845767868 10.1158/0008-5472.CAN-06-1278 (Pubitemid 46009952)
92. De la Motte C. A., Hascall V. C., Drazba J., Bandyopadhyay S. K., Strong S. A., Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid. Inter- α -trypsin inhibitor is crucial to structure and function. American Journal of Pathology 2003 163 1 121 133 2-s2.0-0037969876 (Pubitemid 36759597)
93. Lennon F. E., Singleton P. A., Hyaluronan regulation of vascular integrity. American Journal of Cardiovascular Disease 2011 1 200 213
94. Koyama H., Hibi T., Isogai Z., Yoneda M., Fujimori M., Amano J., Kawakubo M., Kannagi R., Kimata K., Taniguchi S., Itano N., Hyperproduction of hyaluronan in Neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. American Journal of Pathology 2007 170 3 1086 1099 2-s2.0-34247857741 10.2353/ajpath.2007.060793 (Pubitemid 47339375)
95. Koyama H., Kobayashi N., Harada M., Takeoka M., Kawai Y., Sano K., Fujimori M., Amano J., Ohhashi T., Kannagi R., Kimata K., Taniguchi S., Itano N., Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. American Journal of Pathology 2008 172 1 179 193 2-s2.0-38749113916 10.2353/ajpath.2008.070360 (Pubitemid 351186379)
96. Kobayashi N., Miyoshi S., Mikami T., Koyama H., Kitazawa M., Takeoka M., Sano K., Amano J., Isogai Z., Niida S., Oguri K., Okayama M., McDonald J. A., Kimata K., Taniguchi S., Itano N., Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Research 2010 70 18 7073 7083 2-s2.0-77956895204 10.1158/0008-5472.CAN-09-4687
97. Lokeshwar V. B., Schroeder G. L., Carey R. I., Soloway M. S., Iida N., Regulation of hyaluronidase activity by alternative mRNA splicing. Journal of Biological Chemistry 2002 277 37 33654 33663 2-s2.0-0037072801 10.1074/jbc.M203821200
98. Adamia S., Pilarski P. M., Belch A. R., Pilarsk L. M., Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets. Current Cancer Drug Targets 2013 13 4 347 361
99. Turley E. A., Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. Biochemical and Biophysical Research Communications 1983 108 3 1016 1024 2-s2.0-0020522515 (Pubitemid 13072654)
100. Hardwick C., Hoare K., Owens R., Hohn H. P., Hook M., Moore D., Cripps V., Austen L., Nance D. M., Turley E. A., Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. Journal of Cell Biology 1992 117 6 1343 1350 2-s2.0-0026645557 10.1083/jcb.117.6.1343
101. Cheung W.-F., Cruz T. F., Turley E. A., Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochemical Society Transactions 1999 27 2 135 142 2-s2.0-0033050515 (Pubitemid 29086023)
102. Assmann V., Marshall J. F., Fieber C., Hofmann M., Hart I. R., The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. Journal of Cell Science 1998 111 12 1685 1694 2-s2.0-0031850550 (Pubitemid 28330555)
103. Entwistle J., Hall C. L., Turley E. A., HA receptors: regulators of signalling to the cytoskeleton. Journal of Cellular Biochemistry 1996 61 14 569 577 (Pubitemid 26240134)
104. Turley E. A., Hyaluronan and cell locomotion. Cancer and Metastasis Reviews 1992 11 1 21 30 2-s2.0-0026559653 10.1007/BF00047600
105. Klewes L., Turley E. A., Prehm P., The hyaluronate synthase from a eukaryotic cell line. Biochemical Journal 1993 290 3 791 795 2-s2.0-0027414284 (Pubitemid 23100440)
106. Maxwell C. A., Keats J. J., Belch A. R., Pilarski L. M., Reiman T., Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Research 2005 65 3 850 860 2-s2.0-13444294239 (Pubitemid 40216444)
107. Telmer P. G., Tolg C., McCarthy J. B., Turley E. A., How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression? Communicative and Integrative Biology 2011 4 2 182 185 2-s2.0-80155136185 10.4161/cib.4.2.14270
108. Sohr S., Engeland K., RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53. Cell Cycle 2008 7 21 3448 3460 2-s2.0-55849096558
109. Assmann V., Jenkinson D., Marshall J. F., Hart I. R., The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. Journal of Cell Science 1999 112 3943 3954 2-s2.0-0033490051 (Pubitemid 30119764)
110. Evanko S. P., Parks T., Wight T. N., Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. Journal of Histochemistry and Cytochemistry 2004 52 12 1525 1535 2-s2.0-10044236548 10.1369/jhc.4A6356.2004 (Pubitemid 39603252)
111. Tolg C., Hamilton S. R., Morningstar L., Zhang J., Zhang S., Esguerra K. V., Telmer P. G., Luyt L. G., Harrison R., McCarthy J. B., Turley E. A., RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity. Journal of Biological Chemistry 2010 285 34 26461 26474 2-s2.0-77956210930 10.1074/jbc.M110.121491
112. Tolg C., Hamilton S. R., Nakrieko K.-A., Kooshesh F., Walton P., McCarthy J. B., Bissell M. J., Turley E. A., Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. Journal of Cell Biology 2006 175 6 1017 1028 2-s2.0-33845701690 10.1083/jcb.200511027 (Pubitemid 44969206)
113. David-Raoudi M., Tranchepain F., Deschrevel B., Vincent J.-C., Bogdanowicz P., Boumediene K., Pujol J.-P., Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair and Regeneration 2008 16 2 274 287 2-s2.0-40349091710 10.1111/j.1524-475X.2007. 00342.x (Pubitemid 351342119)
114. Adamia S., Maxwell C. A., Pilarski L. M., Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Current Drug Targets 2005 5 1 3 14 2-s2.0-13844299721 10.2174/1568006053005056 (Pubitemid 40246722)
115. Assmann V., Gillett C. E., Poulsom R., Ryder K., Hart I. R., Hanby A. M., The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. Journal of Pathology 2001 195 2 191 196 2-s2.0-0034801805 10.1002/path.941 (Pubitemid 32899028)
116. Wang C., Thor A. D., Moore D. H. II, Zhao Y., Kerschmann R., Stern R., Watson P. H., Turley E. A., The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clinical Cancer Research 1998 4 3 567 576 2-s2.0-0031948476 (Pubitemid 28193554)
117. Hus I., Schmitt M., Tabarkiewicz J., Radej S., Wojas K., Bojarska-Junak A., Schmitt A., Giannopoulos K., Dmoszyńska A., Roliński J., Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+ CD25+ FoxP3+ regulatory T cells toward an antileukemia response. Leukemia 2008 22 5 1007 1017 2-s2.0-43749119376 10.1038/leu.2008.29 (Pubitemid 351689883)
118. Hall C. L., Yang B., Yang X., Zhang S., Turley M., Samuel S., Lange L. A., Wang C., Curpen G. D., Savani R. C., Greenberg A. H., Turley E. A., Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995 82 1 19 28 2-s2.0-0029070913
119. Samuel S. K., Hurta R. A. R., Spearman M. A., Wright J. A., Turley E. A., Greenberg A. H., TGF- β 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. Journal of Cell Biology 1993 123 3 749 758 2-s2.0-0027331078 10.1083/jcb.123.3.749 (Pubitemid 23324930)
120. Amara F. M., Entwistle J., Kuschak T. I., Turley E. A., Wright J. A., Transforming growth factor- β 1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA. Journal of Biological Chemistry 1996 271 25 15279 15284 2-s2.0-0029934319
121. Kouvidi K., Berdiaki A., Nikitovic D., Katonis P., Afratis N., Hascall V. C., Karamanos N. K., Tzanakakis G. N., Role of Receptor for Hyaluronic Acid-mediated Motility (RHAMM) in Low Molecular Weight Hyaluronan (LMWHA)- mediated fibrosarcoma cell adhesion. Journal of Biological Chemistry 2011 286 44 38509 38520 2-s2.0-80055068206 10.1074/jbc.M111.275875
122. Hall C. L., Wang C., Lange L. A., Turley E. A., Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. Journal of Cell Biology 1994 126 2 575 588 2-s2.0-0028241389 10.1083/jcb.126.2.575 (Pubitemid 24226272)
123. Hall C. L., Turley E. A., Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. Journal of Neuro-Oncology 1995 26 3 221 229 2-s2.0-0029610652 10.1007/BF01052625 (Pubitemid 26017811)
124. Guerrero S., Figueras A., Casanova I., Farré L., Lloveras B., Capellà G., Trias M., Mangues R., Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice. The FASEB Journal 2002 16 12 1642 1644 2-s2.0-0036778030
125. DeVivo I., Marion M.-J., Smith S. J., Carney W. P., Brandt-Rauf P. W., Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride. Cancer Causes and Control 1994 5 3 273 278 2-s2.0-0028359206 10.1007/BF01830248 (Pubitemid 24186018)
126. Yoo J., Robinson R. A., H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Cancer 1999 86 58 63 (Pubitemid 29293377)
127. Hong H.-H. L., Devereux T. R., Melnick R. L., Moomaw C. R., Boorman G. A., Sills R. C., Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicologic Pathology 2000 28 4 529 534 2-s2.0-0033854665 (Pubitemid 30622215)
128. Gill S., Stratton M. R., Patterson H., Spurr N. K., Fisher C., Gusterson Cooper B. A. C. S., Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. Oncogene 1991 6 9 1651 1656 2-s2.0-0025879529 (Pubitemid 21924269)
129. Hill M. A., Gong C., Casey T. J., Menon A. G., Mera R., Tod Gillespie A., Giardina J. F., Levine E. A., Hunt J. D., Detection of K-ras mutations in resected primary leiomyosarcoma. Cancer Epidemiology Biomarkers and Prevention 1997 6 12 1095 1100 2-s2.0-0031467622 (Pubitemid 28007423)
130. Oda Y., Takahira T., Kawaguchi K., Yamamoto H., Tamiya S., Matsuda S.,
131. Mohapatra S., Yang X., Wright J. A., Turley E. A., Greenberg A. H., Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. Journal of Experimental Medicine 1996 183 4 1663 1668 2-s2.0-0029935148 10.1084/jem.183.4.1663 (Pubitemid 26134308)
132. Oda Y., Takahira T., Kawaguchi K., Yamamoto H., Tamiya S., Matsuda S., Tanaka K., Iwamoto Y., Tsuneyoshi M., Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features. Histopathology 2004 45 1 29 38 2-s2.0-3242790798 10.1111/j.1365-2559.2004.01886.x (Pubitemid 38969559)
133. Bahassi E. M., Karyala S., Tomlinson C. R., Sartor M. A., Medvedovic M., Hennigan R. F., Critical regulation of genes for tumor cell migration by AP-1. Clinical and Experimental Metastasis 2004 21 4 293 304 2-s2.0-7244220141 10.1023/B:CLIN.0000046132.46946.dd (Pubitemid 39434539)
134. Huang H.-Y., Kang H.-Y., Li C.-F., Eng H.-L., Chou S.-C., Lin C.-N., Hsiung C.-Y., Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Clinical Cancer Research 2006 12 2 487 498 2-s2.0-31544465982 10.1158/1078-0432.CCR-05-1497 (Pubitemid 43166140)
135. Tolg C., Poon R., Fodde R., Turley E. A., Alman B. A., Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Oncogene 2003 22 44 6873 6882 2-s2.0-0242406727 10.1038/sj.onc.1206811 (Pubitemid 37386687)
136. Hatano H., Shigeishi H., Kudo Y., Higashikawa K., Tobiume K., Takata T., Kamata N., Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2. Journal of Bone and Mineral Metabolism 2012 30 3 293 303 2-s2.0-80053363598 10.1007/s00774-011-0318-0
137. Spranger S., Jeremias I., Wilde S., Leisegang M., Stärck L., Mosetter B., Uckert W., Heemskerk M. H. M., Schendel D. J., Frankenberger B., TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo. Blood 2012 119 15 3440 3449 2-s2.0-84859834967 10.1182/blood-2011-06- 357939
138. Casalegno-Garduno R., Meier C., Schmitt A., Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation. Clinical and Developmental Immunology 2012 2012 9 146463 10.1155/2012/146463
139. Benitez A., Yates T. J., Lopez L. E., Cerwinka W. H., Bakkar A., Lokeshwar V. B., Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Research 2011 71 12 4085 4095 2-s2.0-79958816088 10.1158/0008-5472.CAN-10-4610
140. Lokeshwar V. B., Lopez L. E., Munoz D., Chi A., Shirodkar S. P., Lokeshwar S. D., Escudero D. O., Dhir N., Altman N., Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Research 2010 70 7 2613 2623 2-s2.0-77950845327 10.1158/0008-5472.CAN-09-3185
141. Aruffo A., Stamenkovic I., Melnick M., Underhill C. B., Seed B., CD44 is the principal cell surface receptor for hyaluronate. Cell 1990 61 7 1303 1313 2-s2.0-0025282411 10.1016/0092-8674(90)90694-A (Pubitemid 20208834)
142. Lesley J., Hyman R., CD44 structure and function. Frontiers in Bioscience 1998 3 d616 d630 2-s2.0-0001286055
143. Nedvetzki S., Gonen E., Assayag N., Reich R., Williams R. O., Thurmond R. L., Huang J.-F., Neudecker B. A., Wang F.-S., Turley E. A., Naor D., RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proceedings of the National Academy of Sciences of the United States of America 2004 101 52 18081 18086 2-s2.0-19944428853 10.1073/pnas.0407378102 (Pubitemid 40054077)
144. Naor D., Nedvetzki S., Golan I., Melnik L., Faitelson Y., CD44 in cancer. Critical Reviews in Clinical Laboratory Sciences 2002 39 6 527 579 2-s2.0-0036445586 10.1080/10408360290795574 (Pubitemid 35425379)
145. Bourguignon L. Y. W., CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. Journal of Mammary Gland Biology and Neoplasia 2001 6 3 287 297 2-s2.0-0035404863 10.1023/A:1011371523994 (Pubitemid 39600488)
146. Marhaba R., Zöller M., CD44 in cancer progression: adhesion, migration and growth regulation. Journal of Molecular Histology 2004 35 3 211 231 2-s2.0-16544366235 10.1023/B:HIJO.0000032354.94213.69 (Pubitemid 40585308)
147. Bourguignon L. Y. W., Hongbo Z., Shao L., Chen Y. W., CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic acid- mediated breast tumor cell migration. Journal of Biological Chemistry 2000 275 3 1829 1838 2-s2.0-0034695446 10.1074/jbc.275.3.1829 (Pubitemid 30060806)
148. Bourguignon L. Y. W., Singleton P. A., Zhu H., Diedrich F., Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. Journal of Biological Chemistry 2003 278 32 29420 29434 2-s2.0-0043032859 10.1074/jbc.M301885200 (Pubitemid 36962321)
149. Naor D., Sionov R. V., Ish-Shalom D., CD44: structure, function, and association with the malignant process. Advances in Cancer Research 1997 71 241 319 2-s2.0-0030966842 (Pubitemid 27197761)
150. Tammi M. I., Day A. J., Turley E. A., Hyaluronan and homeostasis: a balancing act. Journal of Biological Chemistry 2002 277 7 4581 4584 2-s2.0-0037085475 10.1074/jbc.R100037200 (Pubitemid 34968482)
151. Galluzzo E., Albi N., Fiorucci S., Merigiola C., Ruggeri L., Tosti A., Grossi C. E., Velardi A., Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. European Journal of Immunology 1995 25 10 2932 2939 2-s2.0-0028799880 10.1002/eji.1830251033
152. Pedrinaci S., Algarra I., Garcia Lora A., Gaforio J. J., Perez M., Garrido F., Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. International Journal of Clinical and Laboratory Research 1999 29 4 166 173 2-s2.0-0033505105 10.1007/s005990050085 (Pubitemid 30181284)
153. Culp L. A., Kogerman P., Plasticity of CD44s expression during progression and metastasis of fibrosarcoma in an animal model system. Frontiers in Bioscience 1998 3 d672 d683 2-s2.0-0344544994
154. Kogerman P., Sy M.-S., Culp L. A., Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. Oncogene 1997 15 12 1407 1416 2-s2.0-0030807414 (Pubitemid 27437830)
155. Culp L. A., Tagged tumor cells reveal regulatory steps during earliest stages of tumor progression and micrometastasis. Histology and Histopathology 1999 14 3 879 886 2-s2.0-0033032862 (Pubitemid 29320354)
156. Taniguchi K., Harada N., Ohizumi I., Tsutsumi Y., Nakagawa S., Kaiho S.-I., Mayumi T., Recognition of human activated CD44 by tumor vasculature-targeted antibody. Biochemical and Biophysical Research Communications 2000 269 3 671 675 2-s2.0-0034708357 10.1006/bbrc.2000.2347 (Pubitemid 30440359)
157. Bourguignon L. Y. W., Wong G., Earle C., Krueger K., Spevak C. C., Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. Journal of Biological Chemistry 2010 285 47 36721 36735 2-s2.0-78449234396 10.1074/jbc.M110.162305
158. Rooney P., Kumar S., Ponting J., Wang M., The role of hyaluronan in tumour neovascularization (review). International Journal of Cancer 1995 60 5 632 636 2-s2.0-0028909523 10.1002/ijc.2910600511
159. Rahmanian M., Heldin P., Testicular hyaluronidase induces tubular structures of endothelial cells grown in three-dimensional colagen gel through a CD44-mediated mechanism. International Journal of Cancer 2002 97 5 601 607 2-s2.0-0037050721 10.1002/ijc.10087 (Pubitemid 34087797)
160. Csóka T. B., Frost G. I., Stern R., Hyaluronidases in tissue invasion. Invasion and Metastasis 1997 17 6 297 311 2-s2.0-0040446013 (Pubitemid 29082188)
161. Koshiishi I., Shizari M., Underhill C. B., CD44 can mediate the adhesion of platelets to hyaluronan. Blood 1994 84 2 390 396 2-s2.0-0028337820 (Pubitemid 24215935)
162. Hamilton S. R., Fard S. F., Paiwand F. F., Tolg C., Veiseh M., Wang C., McCarthy J. B., Bissell M. J., Koropatnick J., Turley E. A., The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. Journal of Biological Chemistry 2007 282 22 16667 16680 2-s2.0-34447530390 10.1074/jbc.M702078200 (Pubitemid 47100370)
163. Turley E. A., Naor D., RHAMM and CD44 peptides-analytic tools and potential drugs. Frontiers in Bioscience 2012 17 5 1775 1794 2-s2.0-84859258205 10.2741/4018
164. Hatano H., Shigeishi H., Kudo Y., Higashikawa K., Tobiume K., Takata T., Kamata N., RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR. Laboratory Investigation 2011 91 3 379 391 2-s2.0-79952088448 10.1038/labinvest.2010.176